A study published in Science in 2015 revealed that high-dose VC could trigger apoptosis of BRAF or KRAS mutant colon cancer cells by decreasing intracellular glucose and energy production due to intracellular ROS accumulation and GAPDH inhibition, which was not observed in wild type colon cancer cells (133). This evidence concerns the gene KRAS and malignant colon neoplasm.